We Power the Potential of Episodes. We provide software and services that enable payers, employers and providers to organize and finance healthcare delivery around a patient’s episode of care. We believe that organizing and financing health care around patient episodes of care can transform how health care is purchased, delivered and measured. Bundled payments for comprehensive episodes of care achieve greater cost savings than any other payment model. And Remedy's partners achieve industry-leading financial and patient outcomes. Remedy marries together sophisticated analytics and insights born from dozens of terabytes of data, the expertise of leading pioneers behind the establishment of episodes of care, and best-in-class technology designed uniquely and specifically for episodes, in order to ensure the success of our partners and their episodes of care programs.
Merck is an innovative, global healthcare leader that is committed to improving health and wellbeing around the world. Our core product categories include diabetes, cancer, vaccines and hospital acute care. We continue to focus our research on conditions that represent some of today’s most significant health challenges – like cancer, HIV, HPV, hepatitis C, cardio-metabolic disease, antibiotic-resistant infection and Alzheimer’s disease, and we are on the front lines in the fight against emerging global pandemics, such as Ebola. We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them. At Merck, we’re applying our global reach, financial strength and scientific excellence to do more of what we’re passionate about: improving health and improving lives.
Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment
Greenwich Biosciences is at the forefront of cannabinoid science, leveraging nearly two decades of pioneering investment and research by our parent company GW Pharmaceuticals plc. Our legacy is rooted in unlocking the potential of cannabinoid prescription medicines to address serious conditions that currently have limited or no treatment options.Greenwich Biosciences is the first and only company to pursue and receive FDA approval for a plant-derived cannabinoid therapy that addresses difficult to treat conditions with significant unmet needs.
PwC helps organizations and individuals create the value they're looking for. We're a network of firms in 157 countries with more than 223,000 people. Tell us what matters to you and find out more by visiting us at www.pwc.com. Gain customized access to our insights by downloading our thought leadership on PwC's 365 app - visit iTunes for access: https://itunes.apple.com/us/app/pwcs-365/id689591286?ls=1&mt=8. We help our clients do the extraordinary each and every day. See how at http://pwc.to/1C8tf53
emVitals is a scalable high-touch technology solution that engages individuals along the continuum of emotional health to enable prevention, early identification and connection to care. emVitals partners with employers and providers to deliver a comprehensive, culturally specific, outcomes-based emotional health strategy, shifting from reactive behavioral health to a proactive emotional health model. The emVitals questionnaire helps employees identify emotional health symptoms early and creates a personalized pathway to care. Our masters-level clinicians partner with employees by phone or video to provide a seamless connection to quality care. By proactively engaging employees in assessing their emotional health, emVitals makes it easy for employees to access personalized support to address their emotional health needs. Advanced analytics tools allow employees, providers and organizations to track treatment effectiveness in real time.
Johns Hopkins HealthCare LLC (JHHC) provides health care services for four health plans: Priority Partners Managed Care Organization, Johns Hopkins Employer Health Programs (EHP), Johns Hopkins US Family Health Plan (USFHP) and Johns Hopkins Advantage MD (Advantage MD).
PCORI is authorized by Congress to conduct research to provide information about the best-available evidence to help patients and their health care providers make better-informed health and healthcare decisions. PCORI’s research, which is guided by input from stakeholders across the healthcare community, is intended to give patients and those who care for them with a better understanding of the prevention, treatment and care options available, and the science that supports those options. PCORI is committed to improving health by substantially increasing the quantity, quality, and timeliness of useful, trustworthy information available to support health decisions; speeding the implementation of patient-centered knowledge into practice; and influencing clinical and health care research funded by others to be more patient-centered. For PCORI more information about PCORI, sign up for our email newsletters via www.pcori.org/signup or follow us on Twitter at @PCORI: http://bit.ly/1gix7t5.
Naturally Slim is a common-sense digital counseling program that teaches participants simple skills to change when and how they eat, instead of what they eat. Plus, it creates other health habits leading to increased physical activity, better sleep, less stress and feeling more in control over health long-term.
It is the leading program offered by employers and plan sponsors nationwide to combat obesity-related diseases, like type 2 diabetes, heart disease and more.
Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Around 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries.
Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, strives for global leadership in psychiatry and neurology by improving the lives of patients. One of the world’s leading companies specializing in brain disorders, Lundbeck is focused on innovating treatments for depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
The SleepCharge Program is a sleep health improvement solution that supports individuals with sleep issues by providing personalized sleep care treatment pathways, human-centric and virtual support, and continuous education. Designed to easily work alongside existing well-being initiatives, SleepCharge provides the missing link to overall health improvement by focusing on the diverse sleep health needs of a vast population. While the delivery of SleepCharge is customized to the unique needs of each workforce, our mission stays the same: Healthy Sleep for All SM.
Our work offers more than information; it can inspire hope in patients, families, friends, physicians, and caregivers. Through constant innovation, we can make breakthroughs to help achieve improved outcomes for more individuals living with cancer. That’s why we foster a collaborative culture that motivates us to do our best work and be a partner in every patient's journey. Our approach combines genomic profile products and data services to generate insights that can help doctors match patients to more treatment options and help accelerate the development of new therapies.
Myriad Genetics Inc. is a leading precision medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on five critical success factors: building upon a solid hereditary cancer foundation, growing new product volume, expanding reimbursement coverage for new products, increasing RNA kit revenue internationally and improving profitability with Elevate 2020. For more information on how Myriad is making a difference, please visit the Company's website: www.myriad.com
Optum is a leading health services and innovation company dedicated to helping make the health system work better for everyone. With more than 124,000 people worldwide, Optum combines technology, data and expertise to improve the delivery, quality and efficiency of health care. Optum uniquely collaborates with all participants in health care, connecting them with a shared focus on creating a healthier world. Hospitals, doctors, pharmacies, employers, health plans, government agencies and life sciences companies rely on Optum services and solutions to solve their most complex challenges and meet the growing needs of the people and communities they serve.
Onduo is a virtual clinic dedicated to people with type 2 diabetes. Onduo’s on-demand access to diabetes specialists and integrated technology allows members to leverage proven behavior change methodologies and data-enhanced standard of care. Founded in 2016 as a joint venture between Verily (a subsidiary of Alphabet focused on life sciences and healthcare) and Sanofi, Onduo is dedicated to bringing the most up-to-date care to people living with diabetes everywhere.
MedSavvy is an online service lead by a team of licensed pharmacists, keeping members in-the-know about the effectiveness, safety, and cost of their medications, so they can make informed treatment decisions for themselves and loved ones. MedSavvy pharmacists evaluate scientific evidence to assign medications a letter grade for their effectiveness and safety in treating a specific condition (i.e. A, B, C, D…). They also provide cost information based on health plan benefits, for easy side-by-side comparison of treatment options. Their pharmacists keep an eye on a member’s medications and proactively alert them of relevant safety concerns, recalls, or opportunities to save money on an equally or more effective treatment.
The priority for people’s attention has completely shifted in the US. By focusing on the needs and challenges of healthcare systems, we formulated a strategy to prioritize their goals while addressing the modern habits of patients by engaging and influencing them where they are already spending their time.
DayTwo provides personalized Medical Nutrition Therapy to enable the normalization of blood sugar levels based on an individual’s unique gut-microbiome profile.
Our science rests on 10 years of evidence-based research completed at the Weizmann Institute of Science, published in Cell and later validated by the Mayo Clinic in JAMA. It concluded blood sugar levels in response to foods are highly individualized and therefore can positively impact people with Type II Diabetes.
The nutrition solution, which includes carbs as 30-35% of the personalized recommendations, reduces impact on lifestyle and eliminates negative and significant health risks associated with fad diets, including the ketogenic diet, while increasing adherence and positively impacting blood sugar.
eMindful is the leading provider of purpose-driven mindfulness solutions that improve health and productivity and decrease healthcare costs. We provide evidence-based mindfulness programs for everyday life and chronic conditions and deliver measurable results by helping individuals make every moment matter with greater focus, creativity, and purposeful decisions. Fortune 500 employers partner with eMindful to prevent rising healthcare costs and to recruit and retain a high-performing workforce that is passionate, inspired, and engaged. Leading health plans use eMindful to improve health outcomes, differentiate their business, and improve quality ratings. What sets eMindful apart is our purpose-driven mindfulness and proven outcomes.
Lyra is transforming mental health care by creating a frictionless experience for members, providers, and employers. Using technology and data, we connect companies and their employees to mental health providers, therapy, and coaching programs that work.
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.